Vivo Capital key facts
- Vivo Capital is a venture capital firm based in Palo Alto, California with 23 tracked portfolio companies.
- Notable positions include Tebra Technologies, 35Pharma, Avistone Pharmaceuticals Biotechnology.
- PrivateMarketView records 1 deal participation by Vivo Capital.
- The team roster lists 2 people.
- Vivo Capital reports $418.6M in regulatory assets under management across 16 private funds, per its SEC Form ADV (2026-03).
About Vivo Capital
Founded in 1996, Vivo Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest globally in biopharmaceuticals, specialty pharmaceuticals, medical devices, and other subsectors of the healthcare and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Investment focus
Its SEC Form ADV lists $419 million in regulatory assets under management across 16 private funds (Mar 2026).
Investment activity
Vivo Capital joined 1 recorded round in the last two years. 1 round landed in the last 90 days. Most recently: Expedition Therapeutics (Series B, Aug 2026).
Vivo Capital portfolio at a glance
23 portfolio companies are on record for Vivo Capital, including Tebra Technologies, 35Pharma and Avistone Pharmaceuticals Biotechnology.
17 of the 23 carry a recorded valuation.
Vivo Capital team
2 people are on record at Vivo Capital: 1 managing partner and 1 board member. Senior names include Frank Kung (Co-Founder) and Gaurav Aggarwal (Board Member). 2 of them have a verified direct contact on file.
Vivo Capital at the SEC
Form ADV · 2026-03 · CRD 159868- Regulatory AUM
- $418.6M
- Private fund assets
- $6.5B
- Private funds
- 16 · 6 venture, 6 private equity, 3 other
- Staff
- 62
- Registered office
- PALO ALTO, CA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as VIVO CAPITAL LLC).
- ·The top 10 names in the book — of 23 recorded positions
- ·Watchlist + alerts for Vivo Capital's activity
Portfolio
23 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Tebra Technologies | — | ▮ | ▮ | ▮ |
| 35Pharma | — | ▮ | ▮ | ▮ |
| Avistone Pharmaceuticals Biotechnology | — | ▮ | ▮ | ▮ |
+ 20 more companies · all 23, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Vivo Capital recent deals
1 recordedMembership and data by Private Market View
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Vivo Capital
- What companies does Vivo Capital invest in?
- Vivo Capital has 23 recorded portfolio companies, including Tebra Technologies, 35Pharma, Avistone Pharmaceuticals Biotechnology.
- What is Vivo Capital's AUM?
- Vivo Capital manages approximately $7.5B in assets.